2 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Locally Advanced Pancreas Cancer: new trials by email Literature Review of Locally Advanced Pancreas Cancer trials Research Report on Locally Advanced Pancreas Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. XER-001 - Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer | Phase 1 / Phase 2 | Recruiting | Xerient Pharma | 36 | 2026-01-01 | 2026-08-17 |
| MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial Tumor collection via biopsy, Blood collection, Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI) - Locally Advanced Cervical Carcinoma, Locally Advanced Cervical Cancer | Not applicable | Recruiting | Washington University School of Medicine | 60 | 2024-01-11 | 2026-08-17 |
Pancreatic Neoplasms (2) · Uterine Cervical Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Pancreatic Diseases (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Uterine Cervical Diseases (1)
Blood Specimen Collection (1) · Magnetic Resonance Imaging (1)
Washington University School of Medicine (1) · Xerient Pharma (1)
United States (2)
Michael Waters, M.D., Ph.D. (1)
U54CA274318 (1)